Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market Opportunity Analysis 2018–2026leads to chronic disease, which affects lungs, digestive, and reproductive system. Patients suffering from exocrine pancreatic insufficiency cannot properly digest proteins, fats, and carbohydrates in the food that results in poor absorption of nutrients in the body.
Request Sample Copy of this Business Report @ www.coherentmarketinsights.com/insight/request-sample/2020
Furthermore, EPI is associated with uncomfortable gastrointestinal (GI) symptoms such as bloating, gas, and oily diarrhea that floats and is difficult to flush. The symptoms of EPI may be similar to other gastrointestinal disorders such as Crohn’s disease, celiac disease, irritable bowel syndrome (IBS), ulcerative colitis, and small intestinal bacterial overgrowth (SIBO), which makes EPI difficult to diagnose. However, there are three major tests used for diagnosis of EPI that include, fecal elastase test, fecal fat test, and direct pancreatic function test.
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market – Drivers
Exocrine pancreatic insufficiency is associated with certain diseases and conditions such as chronic pancreatitis, cystic fibrosis, pancreatectomy, pancreatic cancer, gastrointestinal surgery, type I and type III C diabetes, and other conditions including autoimmune pancreatitis, celiac disease, and inflammatory bowel disease. Moreover, high prevalence of these conditions leads to EPI, which in turn fuels growth of exocrine pancreatic insufficiency (EPI) therapeutics market. For instance, according to a report by the Cystic Fibrosis Foundation, 2010, around 1,000 new cases of cystic fibrosis are diagnosed globally every year.
Furthermore, according to a report by the American Lung Association, 2010, cystic fibrosis is the second most inherited disorder in infants in the U.S. The report further stated that around 10 million cases in the U.S are symptomless carriers of the defective cystic fibrosis gene and around 3,708 deaths were reported due to cystic fibrosis between 1999 and 2006. Moreover, pancreatic cancer is a major factor that leads to EPI. According to Cancer Research UK 2015, around 9,800 new pancreatic cancer cases were registered in the U.K. annually, from 2013 to 2015. The report further stated that pancreatic cancer is the 11th most common cancer in the U.K. that accounted for 3% of all new cancer cases, in 2015.
According to the American Cancer Society (ACS), in the U.S 2018, around 55, 440 people are expected to be diagnosed with pancreatic cancer, and around 44,330 people are expected to succumb to pancreatic cancer. Furthermore, according to the National Cancer Institute, from 2011 to 2015, 12.6 per 100,000 new cases of pancreatic cancer were registered, annually, in the U.S.
According to a report by the Diabetes.co.uk, 2018, EPI was more evident in the people with insulin-dependent diabetes. According to the same source, in 2003, a study conducted on around 1,000 diabetic patients found that insulin-dependent diabetes was more likely to produce abnormally low levels of exocrine pancreatic enzymes. Furthermore, between 25% and 50% of insulin-dependent diabetes patients were found to have developed exocrine pancreatic insufficiency. Moreover, high prevalence of diabetes may increase the risk of EPI. For instance, according to International Diabetes Federation (IDF) Diabetes Atlas: 2017, number of people with diabetes, worldwide, aged between 20 to 79 years in 2017 was around US$ 425 million, and the number is estimated to increase to 48% in 2045, accounting for around US$ 629 million.
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market – Regional Analysis
Geographically, the global exocrine pancreatic insufficiency (EPI) therapeutics market is segmented into North America, Latin America, Europe, Middle East, Asia Pacific, and Africa. North America is expected to dominate the global exocrine pancreatic insufficiency (EPI) therapeutics market due to increasing incidence and prevalence cases of these conditions occurring in this region. EPI is mostly characterized with its associated conditions such as cystic fibrosis, pancreatic cancer, chronic pancreatitis, gastrointestinal surgery, and others.
Access Table of Content (TOC) Of the Report @ www.coherentmarketinsights.com/ongoing-insight/toc/2020
Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market – Competitive Analysis
Key players operating in the exocrine pancreatic insufficiency (EPI) therapeutics market include, AbbVie, Inc., Digestive Care, Inc., Janssen Pharmaceuticals, Inc., Anthera Pharmaceuticals, Inc., Allergan plc, AzurRx BioPharma, Inc., and others. Key players operating in this market are focused on product regulatory approvals and acquisition strategies to enhance their share in the market. For instance, in May 2013, AbbVie, Inc. announced the availability of CREON (pancrelipase) 36,000 Lipase-unit Capsules for patients with EPI in the U.S. Furthermore, in May 2018, VIVUS, Inc. entered into definitive agreement with Janssen Pharmaceuticals, Inc. to acquire all the product rights for PANCREAZE (pancrelipase) delayed-release capsules in the U.S. and Canada.
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exocrine Pancreatic Insufficiency (EPI) Therapeutics Market Opportunity Analysis 2018–2026 here
News-ID: 1186657 • Views: 777
More Releases from Coherent Market Insights
High Voltage Equipment Market Set to Witness Steady Growth through (2018-2026)
Global High Voltage Equipment Market - Insights High voltage equipment market study analyzes switchgear, switches, surge arrester, battery sets, disconnector, circuit breaker, insulator, capacitor & filters control equipment, and other equipment prospects. According to Coherent Market Insights, the others segment that includes transformers and other equipment accounted for the largest share in 2018, followed by the switchgear segment. For In depth Information Get Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/2819 This report provides
Bio Jet Fuel Market Technology and Growth Analysis 2019 | Top Players Honeywell …
Bio jet is an aviation fuel made from renewable and naturally derived raw materials. It is mixed with petroleum jet fuel and is suitable for use in a jet engine. Biojet fuels have lower greenhouse gas emissions as compared to petroleum jet fuel. A major challenge for the bio jet market, however, is the lack of a viable source for the production of biofuels on a commercial scale which
Massage Pillow Market Growing Demand 2019 With Top Players Walgreen, Xiamen Well …
Massage pillow uses innovative technology such as deep kneading massage nodes and massage rollers to relieve tension and induce relaxation of the neck, back, and shoulder pain. Massage pillows mitigates fatigue and promotes blood circulation in the body. Massage pillows or cushions have heat features that provide gentle warmth with hot compression effects, which helps to relieve tension, pain, aches, and knots. Request Sample of Report: https://www.coherentmarketinsights.com/insight/request-sample/2735 Key Players Global massage pillow market
Non-Small Cell Lung Cancer Market Industry Trends with Top Players AstraZeneca, …
Cancer is the disease in which cell grows abnormally and may cause a tumor. In lung cancer, the cells of lungs starts to grow in uncontrolled manner later form a tumor and can be spread into other body parts. Small cell lung cancer and non-small cell lung cancer are the two main types of lung cancer. As per the stats of Lung Cancer Alliance (leading nonprofit organization dedicated to fighting
More Releases for EPI
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease. Download the sample report at: https://www.pharmaproff.com/request-sample/1024 Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI
Global Epi Wafer Market 2018 - Nichia, EpiWorks, Norstel, OMMIC
Eminent Market, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
United States Epi Wafer Market: Moving Towards a Brighter Future
Qyresearchreports include new market research report Epi Wafer to its huge collection of research reports. The report here assembles exchange points of view having a place with the United states Epi Wafer market which verbalizes the present-day information and future exposures with reference to the dynamic forces at play. The prime explanation for the examination report is to offer the endorser with a wide outline and make open the satisfying substances
Epi Wafer Market 2017 - GlobalWafers, Nichia, EpiWorks
Apex Research, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on
Epitaxial (Epi) Wafer Market 2017- ASM International, EpiWorks, Jenoptik
Marketreports.biz, recently published a detailed market research study focused on the "Epitaxial (Epi) Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epitaxial (Epi) Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epitaxial (Epi) Wafer industry, and estimates the future trend of Epitaxial
Global Epi Wafer Market 2017 : EpiWorks, GlobalWafers, Nichia, Jenoptik, Norstel
A market study based on the " Epi Wafer Market " across the globe, recently added to the repository of Market Research, is titled ‘Global Epi Wafer Market 2017’. The research report analyses the historical as well as present performance of the worldwide Epi Wafer industry, and makes predictions on the future status of Epi Wafer market on the basis of this analysis. Sample Copy of Report : http://bit.ly/2r1uV4A Top Manufacturers Companies